Miruvor
Sign up
The short answer

What studies of LifeWave X39 patches found

1paper on LifeWave X39 patches
1 (few people)person in 1 study testing LifeWave X39 patches alone
0randomised trials, the strongest kind of study

At a glance, by condition

ME/CFS: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty): 3 findings, all C.

3 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: LifeWave X39 patches might help some people with ME/CFS, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 1 paper.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. LifeWave X39 patches · ME/CFS is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

ME/CFS

Symptoms

Breathlessness1 study · 1 (few people) person received LifeWave X39 patches Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · since summer 2020 (few people)

Breathlessness improved.

The evidence is very uncertain about the effect of LifeWave X39 patches on breathlessness in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    since summer 2020
    Outcome
    not blue-purple or breathless
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Daily functioning1 study · 1 (few people) person received LifeWave X39 patches Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · since summer 2020 (few people)

Daily functioning improved.

The evidence is very uncertain about the effect of LifeWave X39 patches on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    since summer 2020
    Outcome
    wore a dress reserved for swim days only
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Overall symptoms1 study · 1 (few people) person received LifeWave X39 patches Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · 2010 to 2026 · since summer 2020 (few people)

Overall symptoms improved.

The evidence is very uncertain about the effect of LifeWave X39 patches on overall symptoms in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses (2026)

    People in the study
    1 in the study
    Dose
    since summer 2020
    Outcome
    brief and remarkable reprieve
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Side effects

No study of this treatment alone reported side effects we could read.

All papers

  1. Home Alone 2020: A First-Person Case Study on Surviving Modern Pandemics and their Aftermath of Illnesses2026 · case report · 1 in the study
    Summary

    This single-person case study reports the author’s ME/CFS course from 2010 to 2026, with no comparison group and no blinding. Treatments included Valtrex (valacyclovir) eight tablets a day throughout 2016; Xue-Fu-Zhu-Yu-Tang; weekly acupuncture for eighteen months; Lomatium dissectum started in July 2019 and taken daily; Oxymatrine (or Equilibrant); X39 phototherapy patches since summer 2020; concentrated oxygen ninety minutes a day over six months; and xylitol nasal spray since winter 2020. The author reports using laboratory results and her own observations, not a validated symptom scale. After only two weeks of Chinese herbs she had a brief and remarkable reprieve. After six weeks of acupuncture she went, in her case, from being bedridden and dying to dancing; after six months of weekly acupuncture she survived a short flight and reported dancing like a twenty year old. Weekly acupuncture over eighteen months revived her, but did not kill the viruses. Lomatium produced an immediate emotional response called a pathogen “die-off” and left her feeling lighter in body and spirit. Patches restored energy; concentrated oxygen coincided with improvements in pre-diabetes, allergies, arthrosis and breathing. Valtrex viral loads never dropped, and eight tablets a day made her very ill. Harms included not tolerating certain herbs or tablets and medication overload, elimination and withdrawal; she never had the Lomatium rash. The authors state the case cannot show causation.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime